skip-to-main

This information is intended for healthcare professionals in Singapore only

Spikevax JN.1

0.1 mg/mL dispersion for injection

Spikevax JN.1 is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older.

Patient Information Leaflet for multi-dose vial

Summary of Product Characteristics for multi-dose vial

Patient Information Leaflet for pre-filled syringe

Summary of Product Characteristics for pre-filled syringe

Tools

Temperature Excursion Tool

See what to do with vials of the Moderna COVID-19 Vaccine that may have experienced a temperature excursion prior to administering.

Report Adverse Events

You can report any adverse events to Moderna via the Adverse Event Intake Portal.

Contact Moderna

How can we help you?

Report a side effect: Adverse Event Intake Portal
Email us:
WeCare@modernatx.com
Call us: 1-800-622-4937 Monday - Friday 9:00 AM to 5:00 PM SGT (closed holidays)

    © 2025 Moderna, Inc.

    SG-COV-2100003 1/2025